These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8799528)
1. CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. Carrillo JA; Benitez J Br J Clin Pharmacol; 1996 Jun; 41(6):605-8. PubMed ID: 8799528 [TBL] [Abstract][Full Text] [Related]
2. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Relling MV; Lin JS; Ayers GD; Evans WE Clin Pharmacol Ther; 1992 Dec; 52(6):643-58. PubMed ID: 1458773 [TBL] [Abstract][Full Text] [Related]
3. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans. Rasmussen BB; Brøsen K Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764 [TBL] [Abstract][Full Text] [Related]
4. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Chung WG; Kang JH; Park CS; Cho MH; Cha YN Clin Pharmacol Ther; 2000 Mar; 67(3):258-66. PubMed ID: 10741629 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Kashuba AD; Bertino JS; Kearns GL; Leeder JS; James AW; Gotschall R; Nafziger AN Clin Pharmacol Ther; 1998 May; 63(5):540-51. PubMed ID: 9630827 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233 [TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922 [TBL] [Abstract][Full Text] [Related]
8. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Bertilsson L; Carrillo JA; Dahl ML; Llerena A; Alm C; Bondesson U; Lindström L; Rodriguez de la Rubia I; Ramos S; Benitez J Br J Clin Pharmacol; 1994 Nov; 38(5):471-3. PubMed ID: 7893591 [TBL] [Abstract][Full Text] [Related]
9. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities]. Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199 [TBL] [Abstract][Full Text] [Related]
10. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Vistisen K; Poulsen HE; Loft S Carcinogenesis; 1992 Sep; 13(9):1561-8. PubMed ID: 1394840 [TBL] [Abstract][Full Text] [Related]
11. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Saruwatari J; Nakagawa K; Shindo J; Tajiri T; Fujieda M; Yamazaki H; Kamataki T; Ishizaki T Clin Pharmacol Ther; 2002 Aug; 72(2):200-8. PubMed ID: 12189367 [TBL] [Abstract][Full Text] [Related]
12. Absence of effect of terbinafine on the activity of CYP1A2, NAT-2, and xanthine oxidase. Trépanier EF; Nafziger AN; Kearns GL; Kashuba AD; Amsden GW J Clin Pharmacol; 1998 May; 38(5):424-8. PubMed ID: 9602954 [TBL] [Abstract][Full Text] [Related]
13. Genistein alters caffeine exposure in healthy female volunteers. Chen Y; Xiao CQ; He YJ; Chen BL; Wang G; Zhou G; Zhang W; Tan ZR; Cao S; Wang LP; Zhou HH Eur J Clin Pharmacol; 2011 Apr; 67(4):347-353. PubMed ID: 21222115 [TBL] [Abstract][Full Text] [Related]
14. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects. Begas E; Kilindris T; Kouvaras E; Tsioutsioumi A; Kouretas D; Asprodini EK Food Chem Toxicol; 2018 Dec; 122():38-48. PubMed ID: 30266316 [TBL] [Abstract][Full Text] [Related]
15. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577 [TBL] [Abstract][Full Text] [Related]
16. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis. Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060 [TBL] [Abstract][Full Text] [Related]
18. Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers. Begas E; Tsioutsiouliti A; Kouvaras E; Haroutounian SA; Kasiotis KM; Kouretas D; Asprodini E Food Chem Toxicol; 2017 Feb; 100():80-89. PubMed ID: 28011360 [TBL] [Abstract][Full Text] [Related]
19. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Tsutsumi K; Kotegawa T; Matsuki S; Tanaka Y; Ishii Y; Kodama Y; Kuranari M; Miyakawa I; Nakano S Clin Pharmacol Ther; 2001 Aug; 70(2):121-5. PubMed ID: 11503005 [TBL] [Abstract][Full Text] [Related]
20. Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine. Backman JT; Schröder MT; Neuvonen PJ Eur J Clin Pharmacol; 2008 Jan; 64(1):17-24. PubMed ID: 17955229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]